Ammonium Increases TRPC1 Expression Via Cav-1/PTEN/AKT/GSK3β Pathway

Neurochemical Research

Volumn 42, Issue 3, 2017, Pages 762-776

  Wang, Wei ^a   Gu, Li ^a   Verkhratsky, Alexei ^b,c,d   Peng, Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

Author keywords

Ammonium; Astrocyte; Cav 1, PTEN, PI3K AKT; GSK 3 ; Hepatic encephalopathy

Indexed keywords

1 (4 METHOXYBENZYL) 3 (5 NITRO 2 THIAZOLYL)UREA; AMMONIUM CHLORIDE; CAVEOLIN 1; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM SALT; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE INHIBITOR; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; UREASE; AMMONIA; CAV1 PROTEIN, MOUSE; PTEN PROTEIN, MOUSE; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL C;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MEMBRANE; GENETICS; HYPERAMMONEMIA; METABOLISM; PHOSPHORYLATION; TRANSGENIC MOUSE;

AMMONIA; ANIMALS; ASTROCYTES; CAVEOLIN 1; CELL MEMBRANE; CELLS, CULTURED; FEMALE; GLYCOGEN SYNTHASE KINASE 3 BETA; HYPERAMMONEMIA; MALE; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING; TRPC CATION CHANNELS;

EID: 84978091667     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-2004-z     Document Type: Article

References (60)

1. +: separate routes of uptake into glial cells of bee retina. Eur J Neurosci 19:966–976
2. Martinez-Hernandez A, Bell KP, Norenberg MD (1977) Glutamine synthetase: glial localization in brain. Science 195:1356–1358
3. Rose CF, Verkhratsky A, Parpura V (2013) Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 41:1518–1524
4. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ (2010) Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurother 7:452–470
5. Butterworth RF (2010) Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy. Neurochem Int 57:383–388
6. Waniewski RA (1992) Physiological levels of ammonia regulate glutamine synthesis from extracellular glutamate in astrocyte cultures. J Neurochem 58:167–174
7. Rose C, Kresse W, Kettenmann H (2005) Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J Biol Chem 280:20937–20944
8. Haack N, Dublin P, Rose CR (2014) Dysbalance of astrocyte calcium under hyperammonemic conditions. PLoS One 9:e105832
9. 2+ signalling and up-regulates expression of TRPC1 gene in astrocytes in primary cultures and in the in vivo brain. Neurochem Res 39:2127–2135
10. Verkhratsky A, Rodriguez JJ, Parpura V (2012) Calcium signalling in astroglia. Mol Cell Endocrinol 353:45–56
11. 2+ sources for the exocytotic release of glutamate from astrocytes. Biochim Biophys Acta 1813:984–991
12. Görg B, Morwinsky A, Keitel V, Qvartskhava N, Schrör K, Häussinger D (2010) Ammonia triggers exocytotic release of l-glutamate from cultured rat astrocytes. Glia 58:691–705
13. Dai H, Song D, Xu J, Li B, Hertz L, Peng L (2013) Ammonia-induced Na, K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling. Neurochem Int 63:610–625
14. +-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277:18694–18702
15. Xue Z, Li B, Gu L, Hu X, Li M, Butterworth RF, Peng L (2010) Increased Na, K-ATPase alpha2 isoform gene expression by ammonia in astrocytes and in brain in vivo. Neurochem Int 57:395–403
16. 2+ signalling and up-regulates expression of Cav1.2 gene in astrocytes in primary cultures and in the in vivo brain. Acta Physiol (Oxf) 214:261–274
17. Sowa G (2011) Novel insights into the role of caveolin-2 in cell- and tissue-specific signaling and function. Biochem Res Int 2011:809259
18. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289–7304
19. Stary CM, Tsutsumi YM, Patel PM, Head BP, Patel HH, Roth DM (2012) Caveolins: targeting pro-survival signaling in the heart and brain. Front Physiol 3:393
20. Razani B, Lisanti MP (2001) Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest 108:1553–1561
21. Chidlow JH Jr, Sessa WC (2010) Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 86:219–225
22. Zschocke J, Manthey D, Bayatti N, van der Burg B, Goodenough S, Behl C (2002) Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells. J Biol Chem 277:38772–38780
23. Shin T, Kim H, Jin JK, Moon C, Ahn M, Tanuma N, Matsumoto Y (2005) Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 165:11–20
24. Xia H, Khalil W, Kahm J, Jessurun J, Kleidon J, Henke CA (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176:2626–2637
25. Robbins HL, Hague A (2016) The PI3K/Akt pathway in tumors of endocrine tissues. Front Endocrinol (Lausanne) 6:188
26. 1/2 signaling in cancer. J Recept Signal Transduct Res 32:190–195
27. Gould TD, Manji HK (2005) Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30:1223–1237
28. Jope RS, Bijur GN (2002) Mood stabilizers, glycogen synthase kinase-3beta and cell survival. Mol Psychiatry 7(Suppl 1):S35–S45
29. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11960–11965
30. Diemer NH, Laursen H (1977) Glial cell reactions in rats with hyperammoniemia induced by urease or portocaval anastomosis. Acta Neurol Scand 55:425–442
31. Hertz L, Peng L, Lai JC (1998) Functional studies in cultured astrocytes. Methods 16:293–310
32. Hertz L, Schousboe A, Boechler N, Mukerji S, Fedoroff S (1978) Kinetic characteristics of the glutamate uptake into normal astrocytes in cultures. Neurochem Res 3:1–14
33. Hertz L, Juurlink BHJ, Szuchet S (1985) Cell cultures. In: Lajtha A (ed) Handbook of neurochemistry. Plenum Press, New York, pp 603–661
34. Meier E, Hertz L, Schousboe A (1991) Neurotransmitters as developmental signals. Neurochem Int 19:1–15
35. Hertz L, Bender AS, Woodbury DM, White HS (1989) Potassium-stimulated calcium uptake in astrocytes and its potent inhibition by nimodipine. J Neurosci Res 22:209–215
36. 2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berl) 201:443–458
37. 2B receptor density and receptormediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem Res 27:113–120
38. Hsieh SR, Hsu CS, Lu CH, Chen WC, Chiu CH, Liou YM (2013) Epigallocatechin-3-gallate-mediated cardioprotection by Akt/GSK-3β/caveolin signalling in H9c2 rat cardiomyoblasts. J Biomed Sci 20:86
39. Ng LC, McCormack MD, Airey JA, Singer CA, Keller PS, Shen XM, Hume JR (2009) TRPC1 and STIM1 mediate capacitative Ca2 entry in mouse pulmonary arterial mooth muscle cells. J Physiol 587:2429–2442
40. el-Marjou A, Delouvee A, Thiery JP, Radvanyi F (2000) Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression. Carcinogenesis 21:2211–2218
41. Peng L, Martin-vasallo P, Sweadner KJ (1997) Isoforms of Na, K-ATPase alpha and beta subunits in the rat cerebellum and in granule cell cultures. J Neurosci 17:3488–3502
42. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
43. Lovatt D, Sonnewald U, Waagepetersen HS, Schousboe A, He W, Lin JH, Han X, Takano T, Wang S, Sim FJ, Goldman SA, Nedergaard M (2007) The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci 27:12255–12266
44. Fu H, Li B, Hertz L, Peng L (2012) Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH. Neurochem Int 61:187–194
45. Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, Roncali L, Bertossi M (2002) Expression of caveolin-1 in human brain microvessels. Neuroscience 115:145–152
46. Niesman IR, Schilling JM, Shapiro LA, Kellerhals SE, Bonds JA, Kleschevnikov AM, Cui W, Voong A, Krajewski S, Ali SS, Roth DM, Patel HH, Patel PM, Head BP (2014) Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice. J Neuroinflamm 11:39
47. González MI, Krizman-Genda E, Robinson MB (2007) Caveolin-1 regulates the delivery and endocytosis of the glutamate transporter, excitatory amino acid carrier 1. J Biol Chem 282:29855–29865
48. Salgado IK, Serrano M, García JO, Martínez NA, Maldonado HM, Báez-Pagán CA, Lasalde-Dominicci JA, Silva WI (2012) SorLA in glia: shared subcellular distribution patterns with caveolin-1. Cell Mol Neurobiol 32:409–421
49. Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M, Defamie N (2012) Down-regulation of Connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion. Mol Carcinog 51:845–860
50. Kagawa Y, Yasumoto Y, Sharifi K, Ebrahimi M, Islam A, Miyazaki H, Yamamoto Y, Sawada T, Kishi H, Kobayashi S, Maekawa M, Yoshikawa T, Takaki E, Nakai A, Kogo H, Fujimoto T, Owada Y (2015) Fatty acid-binding protein 7 regulates function of caveolae in astrocytes through expression of caveolin-1. Glia 63:780–894
51. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Members of the ISHEN Commission on Experimental Models of HE. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29:783–788
52. Batshaw ML, Hyman SL, Mellits ED, Thomas GH, DeMuro R, Coyle JT (1986) Behavioral and neurotransmitter changes in the urease-infused rat: a model of congenital hyperammonemia. Pediatr Res 20:1310–1315
53. O’Connor JE, Renau-Piqueras J, Grisolía S (1984) Effects of urease-induced hyperammonemia in mouse liver. Ultrastructural, stereologic and biochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 46:187–197
54. Hindfelt B (1975) On mechanisms in hyperammonemic coma-with particular reference to hepatic encephalopathy. Ann N Y Acad Sci 252:116–123
55. Hindfelt B (1975) The distribution of ammonia between extracellular and intracellular compartments of the rat brain. Clin Sci Mol Med 48:33–37
56. Kirischuk S, Parpura V, Verkhratsky A (2012) Sodium dynamics: another key to astroglial excitability? Trends Neurosci 35:497–506
57. Verkhratsky A, Orkand RK, Kettenmann H (1998) Glial calcium: homeostasis and signaling function. Physiol Rev 78:99–141
58. 2+ as a signalling route. ASN Neuro 4:e00080
59. Verkhratsky A (2005) Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 85:201–279
60. Zhou J, Du T, Li B, Rong Y, Verkhratsky A, Peng L (2015) Crosstalk between MAPK/ERK and PI3K/AKT signal pathways during brain ischemia/reperfusion. ASN Neuro. doi:10.1177/1759091415602463